Igor Samatoshenkov | Medicine | Best Researcher Award

Mr. Igor Samatoshenkov | Medicine | Best Researcher Award

Vascular surgeon, Uniclinic Brandenburg, Medical school Brandenburg, Germany

Dr. Samatoshenkov Igor Valeryevich  is an accomplished cardiovascular surgeon, innovator, and medical entrepreneur, currently based in Brandenburg, Germany. With an MD and PhD in medical sciences, he has made significant strides in the fields of vascular surgery, regenerative medicine, and gene therapy. He is the founder and CEO of “Angiolife,” a Skolkovo-based biotech company pioneering gene-drug research. As a dedicated academic and clinical expert, Dr. Samatoshenkov has been actively involved in cutting-edge surgical practice, scientific research, and medical education. 🧬💉

Publication Profile

Scopus

ORCID

🎓 Education Background

Dr. Samatoshenkov earned his PhD in 2021 from Kazan Federal University 🎓. His earlier training includes a medical degree from Kazan State Medical University (2009–2015), where he also specialized as a professional medical translator (2012–2014). He pursued advanced phlebology training in endovenous laser obliteration in 2018 in Moscow. His comprehensive education has built a solid foundation for his clinical and research pursuits. 📚🩺

💼 Professional Experience

Dr. Samatoshenkov has over a decade of experience in cardiovascular surgery and medical education. Since 2017, he has been serving in the Department of Cardiosurgery No. 1 and is a graduate student in the Department of Histology, Cytology, and Embryology. From 2015 to 2017, he was an attending physician in the Department of Heart Surgery at the ICDC. He also contributed to academia as an assistant in the Department of Normal Anatomy (2016–2017) and led several student scientific circles from 2011 to 2014. In 2018, he founded “Angiolife,” advancing gene-based therapeutics. 🏥💡

🏆 Awards and Honors

Dr. Samatoshenkov’s innovations have been widely recognized. He won the 2023 National Competition of Innovative Ideas in Medicine by AMTEC Foundation 🏅 and the “Top 50 Innovative Ideas” contest in Tatarstan 🥇. He was a finalist in the 2022 MEDLEADS competition and ranked 2nd in the 2021 All-Russian Intellectual Property contest “Intellect.” He also received accolades from the Academy of Sciences of Tatarstan (2020) and Innopolis Startup Tour (3rd place). 🌟🔬

🔬 Research Focus

Dr. Samatoshenkov’s research spans cardiovascular regeneration, gene and stem cell therapy, and surgical innovation. His pioneering studies in VEGF, ANG, and GDNF gene delivery have opened promising avenues in post-ischemic tissue recovery. His experimental models and cell-mediated delivery techniques are pushing the boundaries of modern medicine. 🧪🧠

🔚 Conclusion

With an exceptional blend of clinical excellence, scientific ingenuity, and entrepreneurial vision, Dr. Igor Samatoshenkov is a leading figure in cardiovascular innovation and regenerative therapy. His mission continues to bridge advanced research with real-world patient solutions. 🌐

📘 Top Publications

  1. Modeling of acute venous lesion of the lower extremities in experiment (2016) – Clinical and Experimental Surgery
    Authors: I.V. Samatoshenkov, B.M. Mirolyubov
    Cited by: —
    Journal Link: Not publicly available online

  2. Effects of direct and indirect delivery of the VEGF gene by cord blood cells to the area of limb ischemia in rats (2017) – Morphological Statements
    Authors: I.V. Samatoshenkov, S.A. Andreev, N.V. Boychuk
    🔗 https://doi.org/10.20340/mv-mn.2017(25).4.14-17
    Cited by: 5+

  3. Comparison of the effectiveness of stimulating angiogenesis in ischemic limbs… (2019) – Creative Cardiology
    Authors: I.V. Samatoshenkov et al.
    🔗 https://doi.org/10.24022/1997-3187-2019-13-3-250-262
    Cited by: 10+

  4. Stimulation of angiogenesis of rat skeletal muscle… (2020) – Morphology
    🔗 https://doi.org/10.34922/AE.2020.157.1.006
    Cited by: 15+

  5. Adenoviral vector delivery of VEGF, angiogenin, and GDNF genes promotes angiogenesis… (2020) – BioNanoScience
    Authors: I.V. Samatoshenkov et al.
    🔗 https://doi.org/10.1007/s12668-019-00688-y
    Cited by: 25+

  6. New experimental model of hind limb ischemia in pot-bellied pigs (2023) – Microvascular Research
    Authors: Igor Samatoshenkov et al.
    🔗 https://doi.org/10.1016/j.mvr.2022.104425
    Cited by: 8+

  7. Combined delivery of the VEGF, ANG, and GDNF genes stimulates angiogenesis and post-ischemic regeneration (2024) – Current Issues in Molecular Biology
    🔗 https://doi.org/10.3390/cimb46080507
    Cited by: 12+

 

Dr. Andrea Barberis | Health Sciences | Excellence Award (Any Scientific field)

Dr. Andrea Barberis | Health Sciences | Excellence Award (Any Scientific field)

EO Galliera Hospitals, Genoa, Italy

Dr. Andrea Barberis  is a distinguished Italian surgeon with a specialization in general and hepatobiliopancreatic surgery. Currently serving as Dirigente Medico di Primo Livello at the Ente Ospedaliero Ospedali Galliera in Genova, Liguria since 2018, he plays a pivotal role in clinical care and surgical innovation. Dr. Barberis is well recognized within Italian surgical societies for his contributions to both clinical practice and research, particularly in colorectal, emergency, and gastrointestinal surgery.

Publication Profile

🎓 Education Background:

Dr. Barberis earned his specialization in General Surgery from the Università degli Studi di Genova, one of Italy’s premier institutions for medical education. His advanced training has equipped him with the skills to tackle complex surgical conditions, especially in hepatobiliopancreatic and digestive tract domains.

💼 Professional Experience:

Since January 2018, Dr. Barberis has been affiliated with the Ente Ospedaliero Ospedali Galliera in Genoa, where he serves in a leading capacity within the General and Hepatobiliopancreatic Surgery Department. His professional journey reflects not only a commitment to surgical excellence but also active involvement in national surgical networks. He is a member of the Società Ligure di Chirurgia since 2018 and part of the Comitato Nazionale ACOI Giovani (Italian Hospital Surgeons Association) from 2021 to 2024.

🏅 Awards and Honors:

While individual awards are not specifically listed, Dr. Barberis’s leadership roles and active presence in Italy’s most prestigious surgical societies such as ACOI and Società Ligure di Chirurgia are testament to his professional standing and peer recognition.

🔬 Research Focus:

Dr. Barberis’s research interests are deeply rooted in colorectal cancer, minimally invasive surgical techniques, emergency surgery, venous thromboembolism prophylaxis, and digestive tract management, as evidenced by his prolific publication record. He employs machine learning, cross-sectional surveys, and clinical cohort studies to derive impactful insights that advance surgical practice.

🧾 Conclusion:

Dr. Andrea Barberis continues to make significant strides in the field of surgery through his clinical roles, national committee engagements, and high-impact research. A committed physician-scientist, his contributions reflect a blend of surgical precision and academic rigor, helping shape the future of Italian and global surgical practice.

📚 Top Publications with Details:

Dynamic Prediction of Rectal Cancer Relapse and Mortality Using a Landmarking-Based Machine Learning Model
Journal: Cancers | Year: 2025
Cited by: [Available on publisher site]

Protective ileostomy creation after anterior resection of the rectum (PICARR): a decision-making exploring international survey
Journal: Updates in Surgery | Year: 2025
Cited by: [Available on publisher site]

Diagnosis and management of caustic ingestion: an interdisciplinary nationwide cross-sectional survey
Journal: Updates in Surgery | Year: 2025
Cited by: [Available on publisher site]

Extended pharmacological thromboprophylaxis and clinically relevant venous thromboembolism after major abdominal and pelvic surgery
Journal: The British Journal of Surgery | Year: 2025
Cited by: PMC11894929

Acute diverticulitis management: evolving trends among Italian surgeons
Journal: Updates in Surgery | Year: 2024
Cited by: PMC11455713